Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy.

Neurobiology of Aging
Victoria Gomez-MurciaD Blum

Abstract

Epileptic seizures constitute a significant comorbidity of Alzheimer's disease (AD), which are recapitulated in transgenic mouse models of amyloidogenesis. Here, we sought to evaluate the potential role of tau pathology regarding seizure occurrence. To this end, we performed intra-hippocampal electroencephalogram (EEG) recordings and PTZ (pentylenetetrazol) seizure threshold tests in THY-Tau22 transgenic mice of AD-like tau pathology. We demonstrate that despite a lack of spontaneous epileptiform activity in Tau22 mice, the animals display increased PTZ-induced seizure susceptibility and mortality. The increased propensity for induced seizures in THY-Tau22 mutants correlates with astrogliosis and increased expression of adenosine kinase, consistent with increased network excitability. These data support an impact of tau pathology toward AD-associated seizures and suggest that tau pathology may contribute to seizure generation in AD independent of Aβ pathology.

References

May 1, 1997·Neurobiology of Aging·C DuyckaertsJ J Hauw
Jan 23, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicolette GouderDetlev Boison
May 10, 2008·Expert Review of Proteomics·Nicolas SergeantLuc Buée
Mar 20, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rimante MinkevicieneHeikki Tanila
Dec 8, 2010·Nature Reviews. Neurology·Annamaria VezzaniTallie Z Baram
Jan 25, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jerrah K HolthJeffrey L Noebels
Feb 7, 2013·Neurochemistry International·Eleonora AronicaDetlev Boison
Jun 19, 2013·Neurobiology of Disease·Ana M García-CabreroMarina P Sánchez
Aug 2, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah L DeVosTimothy M Miller
Aug 21, 2013·Journal of Alzheimer's Disease : JAD·Ann Van der JeugdRudi D'Hooge
Jul 22, 2014·Annals of Neurology·Ania L GheyaraLennart Mucke
Dec 3, 2014·Molecular Psychiatry·C LaurentD Blum
Dec 4, 2015·Nature Reviews. Neuroscience·Yipeng Wang, Eckhard Mandelkow
May 14, 2016·Science Translational Medicine·Matthew R BrierBeau M Ances
Oct 26, 2016·Brain Research Bulletin·Thomas ArendtMax Holzer
Mar 23, 2017·Lancet Neurology·Keith A VosselBruce L Miller
Apr 8, 2017·Acta Neuropathologica·Tong GuoDiane P Hanger
Sep 16, 2017·Current Opinion in Neurology·Thibaud LebouvierLuc Buée
Oct 21, 2017·Brain : a Journal of Neurology·Alexandre BejaninGil D Rabinovici
Apr 6, 2018·International Journal of Molecular Sciences·Marina P SánchezJosé M Serratosa
Jul 3, 2019·Nature Reviews. Neurology·Annamaria VezzaniTeresa Ravizza
Nov 5, 2019·Frontiers in Cellular Neuroscience·Stefania ZappettiniChristophe Bernard
Nov 22, 2019·Nature·Christina IsingMichael T Heneka
Jan 18, 2020·EMBO Molecular Medicine·Annerieke SierksmaMark Fiers

❮ Previous
Next ❯

Citations

Dec 3, 2020·International Journal of Molecular Sciences·Susanna LopezClaudio Babiloni
Jun 24, 2021·Acta Neuropathologica Communications·Ching-Pang ChangYijuang Chern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.